跳至主要内容
临床试验/TCTR20231026001
TCTR20231026001尚未招募3 期

Early intravenous hydrocortisone in sepsis: a randomized control trial

Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 230 人开始时间: 2023年10月26日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
230

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1.Adult > 18 years
  • 2.Suspected or definite sepsis
  • 3.Hypotension (mean arterial pressure < 65 mmHg)

排除标准

  • 1.Randomization occurred later than 3 hours after the onset of hypotension
  • 2.Causes of shock other than sepsis identified
  • 3.Immunocompromised
  • 4.Hyperglycemic crisis (diabetic ketoacidosis, hyperosmolar hyperglycemic state)
  • 5.Pregnancy
  • 6.Post-cardiac arrest
  • 7.Systemic corticosteroids indicated for other conditions
  • 8.Received systemic corticosteroids within 4 weeks at any dose
  • 9.Cancer patients who are receiving palliative treatment
  • 10.Do-not-resuscitate order

研究者

相似试验